Concepedia

Victoria C. Yan

VC

Statistics

Publications

15

Citations

746

H-Index

12

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

BioVentures (United States)

The University of Texas Health Science Center at Houston

Harvard University

Beth Israel Deaconess Medical Center

Victoria C. Yan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.

Publications per year

2018–2024

15

Publications

15

NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis

Mi Kyung Park, Li Zhang, Kyung‐Won Min et al. · Cell Metabolism · 2021 · 207 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

Victoria C. Yan, Florian L. Müller · ACS Medicinal Chemistry Letters · 2020 · 171 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 103 citations · Full text

Medicine, Cancer Biology, Oncology +4

Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine

Yasaman Barekatain, Jeffrey J. Ackroyd, Victoria C. Yan et al. · Nature Communications · 2021 · 55 citations · Full text

Medicine, Biochemistry, Oncology +17

An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats

Sarah Cook, Luke A. Wittenburg, Victoria C. Yan et al. · Viruses · 2022 · 41 citations · Full text

Veterinary Medicine, Infectious Diseases, Veterinary Pharmacology +16

1–5 of 15